Medpace Holdings Revenue 2014-2024 | MEDP

Medpace Holdings annual/quarterly revenue history and growth rate from 2014 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Medpace Holdings revenue for the quarter ending December 31, 2024 was $0.537B, a 7.66% increase year-over-year.
  • Medpace Holdings revenue for the twelve months ending December 31, 2024 was $2.109B, a 11.84% increase year-over-year.
  • Medpace Holdings annual revenue for 2024 was $2.109B, a 11.84% increase from 2023.
  • Medpace Holdings annual revenue for 2023 was $1.886B, a 29.17% increase from 2022.
  • Medpace Holdings annual revenue for 2022 was $1.46B, a 27.8% increase from 2021.
Medpace Holdings Annual Revenue
(Millions of US $)
2024 $2,109
2023 $1,886
2022 $1,460
2021 $1,142
2020 $926
2019 $861
2018 $705
2017 $436
2016 $422
2015 $359
2014 $326
2013 $273
Medpace Holdings Quarterly Revenue
(Millions of US $)
2024-12-31 $537
2024-09-30 $533
2024-06-30 $528
2024-03-31 $511
2023-12-31 $498
2023-09-30 $492
2023-06-30 $461
2023-03-31 $434
2022-12-31 $394
2022-09-30 $384
2022-06-30 $351
2022-03-31 $331
2021-12-31 $309
2021-09-30 $296
2021-06-30 $278
2021-03-31 $260
2020-12-31 $260
2020-09-30 $230
2020-06-30 $205
2020-03-31 $231
2019-12-31 $230
2019-09-30 $216
2019-06-30 $214
2019-03-31 $201
2018-12-31 $192
2018-09-30 $179
2018-06-30 $170
2018-03-31 $163
2017-12-31 $113
2017-09-30 $111
2017-06-30 $106
2017-03-31 $107
2016-12-31 $108
2016-09-30 $108
2016-06-30 $106
2016-03-31 $100
2015-12-31
2015-09-30 $92
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $8.805B $2.109B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.368B 26.70
Elevance Health (ELV) United States $93.458B 12.06
CVS Health (CVS) United States $81.990B 12.00
Cencora (COR) United States $56.269B 20.42
Natera (NTRA) United States $20.939B 0.00
DiDi Global (DIDIY) China $20.365B 29.93
BioMerieux (BMXMF) France $15.507B 0.00
ICON (ICLR) Ireland $12.058B 10.95
EUROFINS SCIENT (ERFSF) Luxembourg $11.881B 0.00
Solventum (SOLV) United States $11.461B 10.69
CochLear (CHEOY) Australia $11.380B 0.00
Revvity (RVTY) United States $11.373B 19.20
Doximity (DOCS) United States $10.781B 56.07
Viatris (VTRS) United States $9.955B 3.15
Avantor (AVTR) United States $8.647B 12.56
Sonic Healthcare (SKHHY) Australia $8.152B 0.00
HealthEquity (HQY) United States $7.475B 36.77
Charles River Laboratories (CRL) United States $5.761B 11.36
Bausch + Lomb (BLCO) Canada $4.848B 22.13
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Alignment Healthcare (ALHC) United States $3.446B 0.00
Organon (OGN) United States $3.421B 3.45
GeneDx Holdings (WGS) United States $3.283B 389.90
Sotera Health (SHC) United States $3.210B 18.54
BrightSpring Health Services (BTSG) United States $3.069B 31.87
Surgery Partners (SGRY) United States $2.863B 32.84
Concentras Parent (CON) United States $2.815B 14.64
Progyny (PGNY) United States $1.967B 43.32
Premier (PINC) United States $1.862B 11.92
Ardent Health Partners (ARDT) United States $1.806B 0.00
GoodRx Holdings (GDRX) United States $1.788B 38.83
Agilon Health (AGL) United States $1.569B 0.00
PACS (PACS) United States $1.486B 0.00
Teladoc Health (TDOC) United States $1.285B 0.00
Pediatrix Medical (MD) United States $1.078B 9.04
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
CareDx (CDNA) United States $1.008B 17.10
Establishment Labs Holdings (ESTA) $0.873B 0.00
AMN Healthcare Services Inc (AMN) United States $0.770B 6.09
Embecta (EMBC) United States $0.730B 5.00
Nutex Health (NUTX) United States $0.579B 11.35
QDM (QDMI) Hong Kong, SAR China $0.554B 0.00
Auna S.A (AUNA) Luxembourg $0.530B 14.04
Sonida Senior Living (SNDA) United States $0.444B 0.00
InnovAge Holding (INNV) United States $0.412B 0.00
Enhabit (EHAB) United States $0.402B 37.90
LifeMD (LFMD) United States $0.384B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.349B 0.00
SBC Medicals (SBC) United States $0.347B 0.00
DocGo (DCGO) United States $0.233B 9.50
Oncology Institute (TOI) United States $0.189B 0.00
Performant Healthcare (PHLT) United States $0.184B 0.00
Beauty Health (SKIN) United States $0.125B 0.00
Sera Prognostics (SERA) United States $0.112B 0.00
OncoCyte (OCX) United States $0.089B 0.00
Ascend Wellness Holdings (AAWH) United States $0.084B 0.00
So-Young (SY) China $0.084B 0.00
Biodesix (BDSX) United States $0.078B 0.00
Basel Medical Group (BMGL) Singapore $0.077B 0.00
IceCure Medical (ICCM) Israel $0.070B 0.00
NeueHealth (NEUE) United States $0.057B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.021B 0.00
ModivCare (MODV) United States $0.018B 6.32
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00